Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 20 entries
Sorted by: Best Match Show Resources per page
[Guy Chomette (1926-1992)].

Archives d'anatomie et de cytologie pathologiques

Auriol M, Brocheriou C.
PMID: 1605701
Arch Anat Cytol Pathol. 1992;40(1):5-6.

No abstract available.

Cite
Auriol M, Brocheriou C. Guy Chomette (1926-1992). [Guy Chomette (1926-1992)]. Arch Anat Cytol Pathol. 1992;40(1):5-6
Auriol, M., & Brocheriou, C. (1992). Guy Chomette (1926-1992). [Guy Chomette (1926-1992)]. Archives d'anatomie et de cytologie pathologiques, 40(1), 5-6.
Auriol, M, and Brocheriou, C. "Guy Chomette (1926-1992)." [Guy Chomette (1926-1992)]. Archives d'anatomie et de cytologie pathologiques vol. 40,1 (1992): 5-6.
Auriol M, Brocheriou C. Guy Chomette (1926-1992). [Guy Chomette (1926-1992)]. Arch Anat Cytol Pathol. 1992;40(1):5-6. French. PMID: 1605701.
Copy Download .nbib Format: NLM
Immunoadsorption: a new strategy to induce remission in membranous lupus nephritis.

Case reports in nephrology and urology

Ulinski T, Davourie-Salandre A, Brocheriou I, Aoun B.
PMID: 24803916
Case Rep Nephrol Urol. 2014 Mar 19;4(1):37-41. doi: 10.1159/000361014. eCollection 2014 Jan.

We report the case of an 11-year-old previously healthy girl who presented for microscopic hematuria and nephrotic proteinuria with normal renal function, which persisted after 6 months of steroids, angiotensin-converting enzyme inhibitors (ACEi)/angiotensin receptor blockers, hydroxychloroquine, mycophenolic acid and...

Cite
Ulinski T, Davourie-Salandre A, Brocheriou I, et al. Immunoadsorption: a new strategy to induce remission in membranous lupus nephritis. Case Rep Nephrol Urol. 2014;4(1):37-41doi: 10.1159/000361014.
Ulinski, T., Davourie-Salandre, A., Brocheriou, I., & Aoun, B. (2014). Immunoadsorption: a new strategy to induce remission in membranous lupus nephritis. Case reports in nephrology and urology, 4(1), 37-41. https://doi.org/10.1159/000361014
Ulinski, Tim, et al. "Immunoadsorption: a new strategy to induce remission in membranous lupus nephritis." Case reports in nephrology and urology vol. 4,1 (2014): 37-41. doi: https://doi.org/10.1159/000361014
Ulinski T, Davourie-Salandre A, Brocheriou I, Aoun B. Immunoadsorption: a new strategy to induce remission in membranous lupus nephritis. Case Rep Nephrol Urol. 2014 Mar 19;4(1):37-41. doi: 10.1159/000361014. eCollection 2014 Jan. PMID: 24803916; PMCID: PMC4000301.
Copy Download .nbib Format: NLM
Efficacy and Safety of Rituximab in Hepatitis B Virus-Associated PLA2R-Positive Membranous Nephropathy.

Kidney international reports

Berchtold L, Zanetta G, Dahan K, Mihout F, Peltier J, Guerrot D, Brochériou I, Ronco P, Debiec H.
PMID: 29725654
Kidney Int Rep. 2017 Sep 21;3(2):486-491. doi: 10.1016/j.ekir.2017.09.009. eCollection 2018 Mar.

No abstract available.

Cite
Berchtold L, Zanetta G, Dahan K, et al. Efficacy and Safety of Rituximab in Hepatitis B Virus-Associated PLA2R-Positive Membranous Nephropathy. Kidney Int Rep. 2017;3(2):486-491doi: 10.1016/j.ekir.2017.09.009.
Berchtold, L., Zanetta, G., Dahan, K., Mihout, F., Peltier, J., Guerrot, D., Brochériou, I., Ronco, P., & Debiec, H. (2018). Efficacy and Safety of Rituximab in Hepatitis B Virus-Associated PLA2R-Positive Membranous Nephropathy. Kidney international reports, 3(2), 486-491. https://doi.org/10.1016/j.ekir.2017.09.009
Berchtold, Lena, et al. "Efficacy and Safety of Rituximab in Hepatitis B Virus-Associated PLA2R-Positive Membranous Nephropathy." Kidney international reports vol. 3,2 (2018): 486-491. doi: https://doi.org/10.1016/j.ekir.2017.09.009
Berchtold L, Zanetta G, Dahan K, Mihout F, Peltier J, Guerrot D, Brochériou I, Ronco P, Debiec H. Efficacy and Safety of Rituximab in Hepatitis B Virus-Associated PLA2R-Positive Membranous Nephropathy. Kidney Int Rep. 2017 Sep 21;3(2):486-491. doi: 10.1016/j.ekir.2017.09.009. eCollection 2018 Mar. PMID: 29725654; PMCID: PMC5932116.
Copy Download .nbib Format: NLM
Renal toxicities associated with pembrolizumab.

Clinical kidney journal

Izzedine H, Mathian A, Champiat S, Picard C, Mateus C, Routier E, Varga A, Malka D, Leary A, Michels J, Michot JM, Marabelle A, Lambotte O, Amoura Z, Soria JC, Kaaki S, Quellard N, Goujon JM, Brocheriou I.
PMID: 30746132
Clin Kidney J. 2019 Feb;12(1):81-88. doi: 10.1093/ckj/sfy100. Epub 2018 Nov 09.

OBJECTIVE: Expanded clinical experience with patients treated by pembrolizumab has accumulated. However, renal toxicities associated with this anti-programmed cell death 1 agent are poorly described because kidney histology is rarely sought. As a nephrology referral centre, we aimed to...

Cite
Izzedine H, Mathian A, Champiat S, et al. Renal toxicities associated with pembrolizumab. Clin Kidney J. 2018;12(1):81-88doi: 10.1093/ckj/sfy100.
Izzedine, H., Mathian, A., Champiat, S., Picard, C., Mateus, C., Routier, E., Varga, A., Malka, D., Leary, A., Michels, J., Michot, J. M., Marabelle, A., Lambotte, O., Amoura, Z., Soria, J. C., Kaaki, S., Quellard, N., Goujon, J. M., & Brocheriou, I. (2019). Renal toxicities associated with pembrolizumab. Clinical kidney journal, 12(1), 81-88. https://doi.org/10.1093/ckj/sfy100
Izzedine, Hassan, et al. "Renal toxicities associated with pembrolizumab." Clinical kidney journal vol. 12,1 (2019): 81-88. doi: https://doi.org/10.1093/ckj/sfy100
Izzedine H, Mathian A, Champiat S, Picard C, Mateus C, Routier E, Varga A, Malka D, Leary A, Michels J, Michot JM, Marabelle A, Lambotte O, Amoura Z, Soria JC, Kaaki S, Quellard N, Goujon JM, Brocheriou I. Renal toxicities associated with pembrolizumab. Clin Kidney J. 2019 Feb;12(1):81-88. doi: 10.1093/ckj/sfy100. Epub 2018 Nov 09. PMID: 30746132; PMCID: PMC6366307.
Copy Download .nbib Format: NLM
The Exostosin Immunohistochemical Status Differentiates Lupus Membranous Nephropathy Subsets With Different Outcomes.

Kidney international reports

Saïdi M, Brochériou I, Estève E, Tuffet S, Amoura Z, Miyara M, Belenfant X, Ulinski T, Rouvier P, Debiec H, Ronco P, Buob D.
PMID: 34307993
Kidney Int Rep. 2021 May 05;6(7):1977-1980. doi: 10.1016/j.ekir.2021.04.025. eCollection 2021 Jul.

No abstract available.

Cite
Saïdi M, Brochériou I, Estève E, et al. The Exostosin Immunohistochemical Status Differentiates Lupus Membranous Nephropathy Subsets With Different Outcomes. Kidney Int Rep. 2021;6(7):1977-1980doi: 10.1016/j.ekir.2021.04.025.
Saïdi, M., Brochériou, I., Estève, E., Tuffet, S., Amoura, Z., Miyara, M., Belenfant, X., Ulinski, T., Rouvier, P., Debiec, H., Ronco, P., & Buob, D. (2021). The Exostosin Immunohistochemical Status Differentiates Lupus Membranous Nephropathy Subsets With Different Outcomes. Kidney international reports, 6(7), 1977-1980. https://doi.org/10.1016/j.ekir.2021.04.025
Saïdi, Michèle, et al. "The Exostosin Immunohistochemical Status Differentiates Lupus Membranous Nephropathy Subsets With Different Outcomes." Kidney international reports vol. 6,7 (2021): 1977-1980. doi: https://doi.org/10.1016/j.ekir.2021.04.025
Saïdi M, Brochériou I, Estève E, Tuffet S, Amoura Z, Miyara M, Belenfant X, Ulinski T, Rouvier P, Debiec H, Ronco P, Buob D. The Exostosin Immunohistochemical Status Differentiates Lupus Membranous Nephropathy Subsets With Different Outcomes. Kidney Int Rep. 2021 May 05;6(7):1977-1980. doi: 10.1016/j.ekir.2021.04.025. eCollection 2021 Jul. PMID: 34307993; PMCID: PMC8258496.
Copy Download .nbib Format: NLM
Immune Profiling of Combined Hepatocellular- Cholangiocarcinoma Reveals Distinct Subtypes and Activation of Gene Signatures Predictive of Response to Immunotherapy.

Clinical cancer research : an official journal of the American Association for Cancer Research

Nguyen CT, Caruso S, Maille P, Beaufrère A, Augustin J, Favre L, Pujals A, Boulagnon-Rombi C, Rhaiem R, Amaddeo G, di Tommaso L, Luciani A, Regnault H, Brustia R, Scatton O, Charlotte F, Brochériou I, Sommacale D, Soussan P, Leroy V, Laurent A, Le VK, Ta VT, Trinh HS, Tran TL, Gentien D, Rapinat A, Nault JC, Allaire M, Mulé S, Zucman-Rossi J, Pawlotsky JM, Tournigand C, Lafdil F, Paradis V, Calderaro J.
PMID: 34785581
Clin Cancer Res. 2021 Nov 16; doi: 10.1158/1078-0432.CCR-21-1219. Epub 2021 Nov 16.

PURPOSE: Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) is a rare malignancy associated with an overall poor prognosis. We aimed to investigate the immune profile of cHCC-CCA and determine its impact on disease outcome.EXPERIMENTAL DESIGN: We performed a multicenter study of 96 patients...

Cite
Nguyen CT, Caruso S, Maille P, et al. Immune Profiling of Combined Hepatocellular- Cholangiocarcinoma Reveals Distinct Subtypes and Activation of Gene Signatures Predictive of Response to Immunotherapy. Clin Cancer Res. 2021;doi: 10.1158/1078-0432.CCR-21-1219.
Nguyen, C. T., Caruso, S., Maille, P., Beaufrère, A., Augustin, J., Favre, L., Pujals, A., Boulagnon-Rombi, C., Rhaiem, R., Amaddeo, G., di Tommaso, L., Luciani, A., Regnault, H., Brustia, R., Scatton, O., Charlotte, F., Brochériou, I., Sommacale, D., Soussan, P., Leroy, V., Laurent, A., Le, V. K., Ta, V. T., Trinh, H. S., Tran, T. L., Gentien, D., Rapinat, A., Nault, J. C., Allaire, M., Mulé, S., Zucman-Rossi, J., Pawlotsky, J. M., Tournigand, C., Lafdil, F., Paradis, V., & Calderaro, J. (2021). Immune Profiling of Combined Hepatocellular- Cholangiocarcinoma Reveals Distinct Subtypes and Activation of Gene Signatures Predictive of Response to Immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research, . https://doi.org/10.1158/1078-0432.CCR-21-1219
Nguyen, Cong Trung, et al. "Immune Profiling of Combined Hepatocellular- Cholangiocarcinoma Reveals Distinct Subtypes and Activation of Gene Signatures Predictive of Response to Immunotherapy." Clinical cancer research : an official journal of the American Association for Cancer Research vol. (2021). doi: https://doi.org/10.1158/1078-0432.CCR-21-1219
Nguyen CT, Caruso S, Maille P, Beaufrère A, Augustin J, Favre L, Pujals A, Boulagnon-Rombi C, Rhaiem R, Amaddeo G, di Tommaso L, Luciani A, Regnault H, Brustia R, Scatton O, Charlotte F, Brochériou I, Sommacale D, Soussan P, Leroy V, Laurent A, Le VK, Ta VT, Trinh HS, Tran TL, Gentien D, Rapinat A, Nault JC, Allaire M, Mulé S, Zucman-Rossi J, Pawlotsky JM, Tournigand C, Lafdil F, Paradis V, Calderaro J. Immune Profiling of Combined Hepatocellular- Cholangiocarcinoma Reveals Distinct Subtypes and Activation of Gene Signatures Predictive of Response to Immunotherapy. Clin Cancer Res. 2021 Nov 16; doi: 10.1158/1078-0432.CCR-21-1219. Epub 2021 Nov 16. PMID: 34785581.
Copy Download .nbib Format: NLM
Mushroom Poisoning Presenting With Acute Kidney Injury and Elevated Transaminases.

Kidney international reports

Beaumier M, Rioult JP, Georges M, Brocheriou I, Lobbedez T, Lanot A.
PMID: 31194187
Kidney Int Rep. 2019 Mar 04;4(6):877-881. doi: 10.1016/j.ekir.2019.02.016. eCollection 2019 Jun.

No abstract available.

Cite
Beaumier M, Rioult JP, Georges M, et al. Mushroom Poisoning Presenting With Acute Kidney Injury and Elevated Transaminases. Kidney Int Rep. 2019;4(6):877-881doi: 10.1016/j.ekir.2019.02.016.
Beaumier, M., Rioult, J. P., Georges, M., Brocheriou, I., Lobbedez, T., & Lanot, A. (2019). Mushroom Poisoning Presenting With Acute Kidney Injury and Elevated Transaminases. Kidney international reports, 4(6), 877-881. https://doi.org/10.1016/j.ekir.2019.02.016
Beaumier, Mathilde, et al. "Mushroom Poisoning Presenting With Acute Kidney Injury and Elevated Transaminases." Kidney international reports vol. 4,6 (2019): 877-881. doi: https://doi.org/10.1016/j.ekir.2019.02.016
Beaumier M, Rioult JP, Georges M, Brocheriou I, Lobbedez T, Lanot A. Mushroom Poisoning Presenting With Acute Kidney Injury and Elevated Transaminases. Kidney Int Rep. 2019 Mar 04;4(6):877-881. doi: 10.1016/j.ekir.2019.02.016. eCollection 2019 Jun. PMID: 31194187; PMCID: PMC6551513.
Copy Download .nbib Format: NLM
Azathioprine as successful maintenance therapy in IgG4-related tubulointerstitial nephritis.

Clinical kidney journal

Pozdzik AA, Brochériou I, Demetter P, Matos C, Delhaye M, Devière J, Nortier JL.
PMID: 26069770
Clin Kidney J. 2012 Jun;5(3):225-8. doi: 10.1093/ckj/sfs048. Epub 2012 May 03.

A 65-year-old man presented with a progressive increase in plasma creatinine (PCr). Two years before, diffusion-weighted magnetic resonance imaging had revealed a relapse of immunoglobulin G4 (IgG4)-related autoimmune pancreatitis (AIP) associated with sclerosing cholangitis. Bilateral hypointense renal cortical nodules...

Cite
Pozdzik AA, Brochériou I, Demetter P, et al. Azathioprine as successful maintenance therapy in IgG4-related tubulointerstitial nephritis. Clin Kidney J. 2012;5(3):225-8doi: 10.1093/ckj/sfs048.
Pozdzik, A. A., Brochériou, I., Demetter, P., Matos, C., Delhaye, M., Devière, J., & Nortier, J. L. (2012). Azathioprine as successful maintenance therapy in IgG4-related tubulointerstitial nephritis. Clinical kidney journal, 5(3), 225-8. https://doi.org/10.1093/ckj/sfs048
Pozdzik, Agnieszka A, et al. "Azathioprine as successful maintenance therapy in IgG4-related tubulointerstitial nephritis." Clinical kidney journal vol. 5,3 (2012): 225-8. doi: https://doi.org/10.1093/ckj/sfs048
Pozdzik AA, Brochériou I, Demetter P, Matos C, Delhaye M, Devière J, Nortier JL. Azathioprine as successful maintenance therapy in IgG4-related tubulointerstitial nephritis. Clin Kidney J. 2012 Jun;5(3):225-8. doi: 10.1093/ckj/sfs048. Epub 2012 May 03. PMID: 26069770; PMCID: PMC4400520.
Copy Download .nbib Format: NLM
Identification of Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer by Fourier-Transform Infrared Micro-Imaging.

Cancers

Mazza C, Gaydou V, Eymard JC, Birembaut P, Untereiner V, Côté JF, Brocheriou I, Coeffic D, Villena P, Larré S, Vuiblet V, Piot O.
PMID: 35008184
Cancers (Basel). 2021 Dec 21;14(1). doi: 10.3390/cancers14010021.

BACKGROUND: Neoadjuvant chemotherapy (NAC) improves survival in responder patients. However, for non-responders, the treatment represents an ineffective exposure to chemotherapy and its potential adverse events. Predicting the response to treatment is a major issue in the therapeutic management of...

Cite
Mazza C, Gaydou V, Eymard JC, et al. Identification of Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer by Fourier-Transform Infrared Micro-Imaging. Cancers (Basel). 2021;14(1)doi: 10.3390/cancers14010021.
Mazza, C., Gaydou, V., Eymard, J. C., Birembaut, P., Untereiner, V., Côté, J. F., Brocheriou, I., Coeffic, D., Villena, P., Larré, S., Vuiblet, V., & Piot, O. (2021). Identification of Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer by Fourier-Transform Infrared Micro-Imaging. Cancers, 14(1), . https://doi.org/10.3390/cancers14010021
Mazza, Camille, et al. "Identification of Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer by Fourier-Transform Infrared Micro-Imaging." Cancers vol. 14,1 (2021). doi: https://doi.org/10.3390/cancers14010021
Mazza C, Gaydou V, Eymard JC, Birembaut P, Untereiner V, Côté JF, Brocheriou I, Coeffic D, Villena P, Larré S, Vuiblet V, Piot O. Identification of Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer by Fourier-Transform Infrared Micro-Imaging. Cancers (Basel). 2021 Dec 21;14(1). doi: 10.3390/cancers14010021. PMID: 35008184.
Copy Download .nbib Format: NLM
Immune profiling of combined hepatocellular-cholangiocarcinoma reveals distinct subtypes and activation of gene signatures predictive of response to immunotherapy.

Clinical cancer research : an official journal of the American Association for Cancer Research

Nguyen CT, Caruso S, Maillé P, Beaufrère A, Augustin J, Favre L, Pujals A, Boulagnon-Rombi C, Rhaiem R, Amaddeo G, Di Tommaso L, Luciani A, Regnault H, Brustia R, Scatton O, Charlotte F, Brocheriou I, Sommacale D, Soussan P, Leroy V, Laurent A, Le VK, Ta VT, Trinh HS, Tran TL, Gentien D, Rapinat A, Nault JC, Allaire M, Mulé S, Zucman-Rossi J, Pawlotsky JM, Tournigand C, Lafdil F, Paradis V, Calderaro J.
PMID: 34785581
Clin Cancer Res. 2021 Nov 16; doi: 10.1158/1078-0432.CCR-21-1219. Epub 2021 Nov 16.

No abstract available.

Cite
Nguyen CT, Caruso S, Maillé P, et al. Immune profiling of combined hepatocellular-cholangiocarcinoma reveals distinct subtypes and activation of gene signatures predictive of response to immunotherapy. Clin Cancer Res. 2021;doi: 10.1158/1078-0432.CCR-21-1219.
Nguyen, C. T., Caruso, S., Maillé, P., Beaufrère, A., Augustin, J., Favre, L., Pujals, A., Boulagnon-Rombi, C., Rhaiem, R., Amaddeo, G., Di Tommaso, L., Luciani, A., Regnault, H., Brustia, R., Scatton, O., Charlotte, F., Brocheriou, I., Sommacale, D., Soussan, P., Leroy, V., Laurent, A., Le, V. K., Ta, V. T., Trinh, H. S., Tran, T. L., Gentien, D., Rapinat, A., Nault, J. C., Allaire, M., Mulé, S., Zucman-Rossi, J., Pawlotsky, J. M., Tournigand, C., Lafdil, F., Paradis, V., & Calderaro, J. (2021). Immune profiling of combined hepatocellular-cholangiocarcinoma reveals distinct subtypes and activation of gene signatures predictive of response to immunotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research, . https://doi.org/10.1158/1078-0432.CCR-21-1219
Nguyen, Cong Trung, et al. "Immune profiling of combined hepatocellular-cholangiocarcinoma reveals distinct subtypes and activation of gene signatures predictive of response to immunotherapy." Clinical cancer research : an official journal of the American Association for Cancer Research vol. (2021). doi: https://doi.org/10.1158/1078-0432.CCR-21-1219
Nguyen CT, Caruso S, Maillé P, Beaufrère A, Augustin J, Favre L, Pujals A, Boulagnon-Rombi C, Rhaiem R, Amaddeo G, Di Tommaso L, Luciani A, Regnault H, Brustia R, Scatton O, Charlotte F, Brocheriou I, Sommacale D, Soussan P, Leroy V, Laurent A, Le VK, Ta VT, Trinh HS, Tran TL, Gentien D, Rapinat A, Nault JC, Allaire M, Mulé S, Zucman-Rossi J, Pawlotsky JM, Tournigand C, Lafdil F, Paradis V, Calderaro J. Immune profiling of combined hepatocellular-cholangiocarcinoma reveals distinct subtypes and activation of gene signatures predictive of response to immunotherapy. Clin Cancer Res. 2021 Nov 16; doi: 10.1158/1078-0432.CCR-21-1219. Epub 2021 Nov 16. PMID: 34785581.
Copy Download .nbib Format: NLM
Acute Tubular Injury and Renal Arterial Myocyte Vacuolization Following Crizotinib Administration.

Kidney international reports

Izzedine H, Brocheriou I, Amoura Z, Mathian A.
PMID: 33615078
Kidney Int Rep. 2020 Dec 01;6(2):526-528. doi: 10.1016/j.ekir.2020.11.029. eCollection 2021 Feb.

No abstract available.

Cite
Izzedine H, Brocheriou I, Amoura Z, et al. Acute Tubular Injury and Renal Arterial Myocyte Vacuolization Following Crizotinib Administration. Kidney Int Rep. 2020;6(2):526-528doi: 10.1016/j.ekir.2020.11.029.
Izzedine, H., Brocheriou, I., Amoura, Z., & Mathian, A. (2021). Acute Tubular Injury and Renal Arterial Myocyte Vacuolization Following Crizotinib Administration. Kidney international reports, 6(2), 526-528. https://doi.org/10.1016/j.ekir.2020.11.029
Izzedine, Hassan, et al. "Acute Tubular Injury and Renal Arterial Myocyte Vacuolization Following Crizotinib Administration." Kidney international reports vol. 6,2 (2021): 526-528. doi: https://doi.org/10.1016/j.ekir.2020.11.029
Izzedine H, Brocheriou I, Amoura Z, Mathian A. Acute Tubular Injury and Renal Arterial Myocyte Vacuolization Following Crizotinib Administration. Kidney Int Rep. 2020 Dec 01;6(2):526-528. doi: 10.1016/j.ekir.2020.11.029. eCollection 2021 Feb. PMID: 33615078; PMCID: PMC7879097.
Copy Download .nbib Format: NLM
Fluindione-induced immuno-allergic interstitial nephritis.

NDT plus

Kheder-Elfekih R, Poitou C, Brocheriou I, Depreneuf H, Izzedine H.
PMID: 25949292
NDT Plus. 2009 Feb;2(1):72-5. doi: 10.1093/ndtplus/sfn171. Epub 2008 Nov 21.

No abstract available.

Cite
Kheder-Elfekih R, Poitou C, Brocheriou I, et al. Fluindione-induced immuno-allergic interstitial nephritis. NDT Plus. 2008;2(1):72-5doi: 10.1093/ndtplus/sfn171.
Kheder-Elfekih, R., Poitou, C., Brocheriou, I., Depreneuf, H., & Izzedine, H. (2009). Fluindione-induced immuno-allergic interstitial nephritis. NDT plus, 2(1), 72-5. https://doi.org/10.1093/ndtplus/sfn171
Kheder-Elfekih, Rania, et al. "Fluindione-induced immuno-allergic interstitial nephritis." NDT plus vol. 2,1 (2009): 72-5. doi: https://doi.org/10.1093/ndtplus/sfn171
Kheder-Elfekih R, Poitou C, Brocheriou I, Depreneuf H, Izzedine H. Fluindione-induced immuno-allergic interstitial nephritis. NDT Plus. 2009 Feb;2(1):72-5. doi: 10.1093/ndtplus/sfn171. Epub 2008 Nov 21. PMID: 25949292; PMCID: PMC4421494.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 20 entries